Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Equity Ratio (2019 - 2025)

Silo Pharma (SILO) has disclosed Equity Ratio for 7 consecutive years, with 0.83 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 22.07% to 0.83 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.83 through Dec 2025, up 22.07% year-over-year, with the annual reading at 0.83 for FY2025, 22.07% up from the prior year.
  • Equity Ratio hit 0.83 in Q4 2025 for Silo Pharma, up from 0.78 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.91 in Q3 2022 to a low of 0.68 in Q4 2024.
  • Historically, Equity Ratio has averaged 0.81 across 5 years, with a median of 0.8 in 2023.
  • Biggest five-year swings in Equity Ratio: skyrocketed 218.56% in 2021 and later fell 14.82% in 2024.
  • Year by year, Equity Ratio stood at 0.86 in 2021, then increased by 2.81% to 0.89 in 2022, then fell by 10.22% to 0.8 in 2023, then dropped by 14.82% to 0.68 in 2024, then rose by 22.07% to 0.83 in 2025.
  • Business Quant data shows Equity Ratio for SILO at 0.83 in Q4 2025, 0.78 in Q3 2025, and 0.74 in Q2 2025.